Safety of FLT3 inhibitors in patients with acute myeloid leukemia
C Cerchione, A Peleteiro Raindo… - Expert Review of …, 2021 - Taylor & Francis
Introduction: Acute myeloblastic leukemia (AML) is the most frequent type of acute leukemia
in adults with an incidence of 4.2 cases per 100,000 inhabitants and poor 5-year survival …
in adults with an incidence of 4.2 cases per 100,000 inhabitants and poor 5-year survival …
Safety of FLT3 inhibitors in patients with acute myeloid leukemia.
C Cerchione, G Marconi, A Isidori, PE MM… - Expert Review of …, 2021 - europepmc.org
Introduction: Acute myeloblastic leukemia (AML) is the most frequent type of acute leukemia
in adults with an incidence of 4.2 cases per 100,000 inhabitants and poor 5-year survival …
in adults with an incidence of 4.2 cases per 100,000 inhabitants and poor 5-year survival …
Safety of FLT3 inhibitors in patients with acute myeloid leukemia
C Cerchione, AP Raíndo… - Expert review of …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction: Acute myeloblastic leukemia (AML) is the most frequent type of acute leukemia
in adults with an incidence of 4.2 cases per 100,000 inhabitants and poor 5-year survival …
in adults with an incidence of 4.2 cases per 100,000 inhabitants and poor 5-year survival …